Beverly Green to Aged
This is a "connection" page, showing publications Beverly Green has written about Aged.
Connection Strength
1.945
-
Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program. J Community Health. 2020 10; 45(5):916-921.
Score: 0.087
-
Colorectal cancer screening: The costs and benefits of getting to 80% in every community. Cancer. 2020 09 15; 126(18):4110-4113.
Score: 0.086
-
A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer. 2017 Nov 15; 123(22):4472-4480.
Score: 0.070
-
Colorectal Cancer Screening Rates Increased after Exposure to the Patient-Centered Medical Home (PCMH). J Am Board Fam Med. 2016 Mar-Apr; 29(2):191-200.
Score: 0.063
-
A Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why Did it Work? J Gen Intern Med. 2015 Nov; 30(11):1665-72.
Score: 0.062
-
Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial. Cancer. 2016 Jan 15; 122(2):312-21.
Score: 0.062
-
Recruiting community health centers into pragmatic research: Findings from STOP CRC. Clin Trials. 2016 Apr; 13(2):214-22.
Score: 0.061
-
Relationship between cardiovascular risk and lipid testing in one health care system: a retrospective cohort study. BMC Health Serv Res. 2015 Jul 23; 15:281.
Score: 0.061
-
Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study. BMC Public Health. 2015 Jun 11; 15:546.
Score: 0.060
-
An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015 Jun; 48(6):714-21.
Score: 0.060
-
Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med. 2014 Nov-Dec; 27(6):789-95.
Score: 0.058
-
Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014 Sep; 66:123-30.
Score: 0.056
-
Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials. 2014 Jul; 38(2):344-9.
Score: 0.056
-
Time to screening in the systems of support to increase colorectal cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1683-8.
Score: 0.056
-
Navigating the murky waters of colorectal cancer screening and health reform. Am J Public Health. 2014 Jun; 104(6):982-6.
Score: 0.056
-
e-Care for heart wellness: a feasibility trial to decrease blood pressure and cardiovascular risk. Am J Prev Med. 2014 Apr; 46(4):368-77.
Score: 0.055
-
Advantages of wordless instructions on how to complete a fecal immunochemical test: lessons from patient advisory council members of a federally qualified health center. J Cancer Educ. 2014 Mar; 29(1):86-90.
Score: 0.055
-
Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes. BMC Cancer. 2014 Feb 26; 14:55.
Score: 0.055
-
Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med. 2013 Nov; 57(5):671-8.
Score: 0.053
-
An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):301-11.
Score: 0.051
-
Using body mass index data in the electronic health record to calculate cardiovascular risk. Am J Prev Med. 2012 Apr; 42(4):342-7.
Score: 0.048
-
Nonparticipation in a population-based trial to increase colorectal cancer screening. Am J Prev Med. 2012 Apr; 42(4):390-7.
Score: 0.048
-
Accuracy of blood pressure measurements reported in an electronic medical record during routine primary care visits. J Clin Hypertens (Greenwich). 2011 Nov; 13(11):821-8.
Score: 0.046
-
Patient ability and willingness to participate in a web-based intervention to improve hypertension control. J Med Internet Res. 2011 Jan 20; 13(1):e1.
Score: 0.044
-
Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010 Nov; 31(6):589-603.
Score: 0.043
-
Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008 Jun 25; 299(24):2857-67.
Score: 0.037
-
Electronic communications and home blood pressure monitoring (e-BP) study: design, delivery, and evaluation framework. Contemp Clin Trials. 2008 May; 29(3):376-95.
Score: 0.035
-
How do minor changes in the definition of blood pressure control affect the reported success of hypertension treatment? Am J Manag Care. 2003 Mar; 9(3):219-24.
Score: 0.026
-
Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening. JAMA Netw Open. 2023 03 01; 6(3):e234052.
Score: 0.026
-
Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):37-45.
Score: 0.025
-
Measured weight loss as a precursor to cancer diagnosis: retrospective cohort analysis of 43 302 primary care patients. J Cachexia Sarcopenia Muscle. 2022 Oct; 13(5):2492-2503.
Score: 0.025
-
Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults. Contemp Clin Trials. 2021 12; 111:106593.
Score: 0.023
-
Cardiovascular Events and Costs With Home Blood Pressure Telemonitoring and Pharmacist Management for Uncontrolled Hypertension. Hypertension. 2020 10; 76(4):1097-1103.
Score: 0.022
-
Barriers and Facilitators to Timely Colonoscopy Completion for Safety Net Clinic Patients. Am J Health Behav. 2020 07 01; 44(4):460-472.
Score: 0.021
-
Self-monitoring of Blood Pressure in Patients With Hypertension-Related Multi-morbidity: Systematic Review and Individual Patient Data Meta-analysis. Am J Hypertens. 2020 03 13; 33(3):243-251.
Score: 0.021
-
First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders. BMC Health Serv Res. 2020 Feb 21; 20(1):132.
Score: 0.021
-
Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening. Sci Rep. 2020 02 12; 10(1):2441.
Score: 0.021
-
Design of a pragmatic cluster-randomized trial comparing telehealth care and best practice clinic-based care for uncontrolled high blood pressure. Contemp Clin Trials. 2020 05; 92:105939.
Score: 0.021
-
Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial. Trials. 2020 Jan 15; 21(1):91.
Score: 0.021
-
Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study. Cancer. 2020 02 01; 126(3):540-548.
Score: 0.020
-
Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers. J Community Health. 2018 02; 43(1):128-136.
Score: 0.018
-
Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management. J Am Soc Hypertens. 2016 11; 10(11):873-880.
Score: 0.016
-
The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics. Fam Pract. 2016 12; 33(6):639-643.
Score: 0.016
-
A substudy evaluating treatment intensification on medication adherence among hypertensive patients receiving home blood pressure telemonitoring and pharmacist management. J Clin Pharm Ther. 2016 Oct; 41(5):493-8.
Score: 0.016
-
Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. Am J Prev Med. 2016 10; 51(4):507-12.
Score: 0.016
-
Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50.
Score: 0.016
-
Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst. 2014 Apr; 106(4):dju032.
Score: 0.014
-
Physician-patient colorectal cancer screening discussions by physicians' screening rates. J Am Board Fam Med. 2012 Nov-Dec; 25(6):771-81.
Score: 0.013